January 14: Clintons Defy Subpoenas; House Eyes Contempt Vote
Bill Clinton Epstein testimony sits at the center of a high‑stakes Washington fight after Bill and Hillary Clinton declined to appear before the House Oversight Committee. Chairman James Comer signaled a contempt of Congress move next week. For investors in Germany, this Jeffrey Epstein probe adds headline risk and could broaden subpoena power toward corporate leaders in tech, pharma, and finance. We outline what happened, how the process works, and the key sector and portfolio implications to watch.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →